Johnson Johnson Aktie
133,86
EUR
-0,40
EUR
-0,30
%
155,28
USD
+0,14
USD
+0,09
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Abbott Laboratories | 0 | 0 | 0 | - | - |
Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
Allergan Inc. | 0 | 0 | 0 | - | - |
APONTIS PHARMA | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 5 | 3 | 0 | 136,58 GBP | +30,13% |
Bayer | 2 | 7 | 0 | 26,86 EUR | -2,13% |
Beiersdorf AG | 8 | 1 | 2 | 141,30 EUR | +30,11% |
BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +22,30% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
Celgene Corp. | 0 | 0 | 0 | - | - |
CureVac | 0 | 2 | 0 | - | - |
Douglas | 3 | 1 | 0 | 15,62 EUR | +48,76% |
Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 49,62 EUR | +7,29% |
Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,29 EUR | +18,91% |
GSK PLC Registered Shs | 1 | 6 | 1 | 16,33 GBP | +16,43% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Merck Co. | 0 | 0 | 0 | - | - |
Merck KGaA | 7 | 1 | 0 | 163,50 EUR | +48,77% |
Moderna Inc | 0 | 2 | 1 | 67,33 USD | +113,20% |
MorphoSys | 0 | 0 | 0 | - | - |
Nestlé SA (Nestle) | 3 | 7 | 1 | 86,50 CHF | +12,94% |
Novartis AG | 3 | 5 | 1 | 100,00 CHF | +4,10% |
Novavax Inc. | 0 | 0 | 0 | - | - |
Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +18,53% |
Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +15,93% |
Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
Sanofi S.A. | 6 | 3 | 0 | 113,12 EUR | +36,77% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
STADA | 0 | 0 | 0 | - | - |
Unilever plc | 6 | 1 | 3 | 48,24 GBP | +7,97% |
Valneva | 0 | 0 | 0 | - | - |